Advertisement
Odomzo (sonidegib) has been approved by the U.S. Food and Drug Administration to treat locally advanced basal cell carcinoma that has returned despite surgery or radiation. The treatment is sanctioned for people who are not candidates for additional surgery or radiation.

FDA Approves Odomzo for Recurring Basal Cell Carcinoma

0
Medication is designed to inhibit the Hedgehog pathway
Many U.S. hospitals overestimate their ability to provide fast delivery of tissue plasminogen activator to stroke patients

Adherence to Stroke Guidelines Overestimated by Hospitals

0
Study shows delivery of tissue plasminogen activator is often later than staff believes
A drug called solanezumab may slow Alzheimer's disease progression by about one-third

AAIC: Hints That New Drug May Slow Alzheimer’s Progression

0
Initial findings need to be supported by additional studies
For contacts of individuals with multidrug-resistant tuberculosis

Fluoroquinolones Halt Multidrug-Resistant-TB in Contacts

0
FQN preventive therapy linked to health system savings and lower mortality versus no therapy
Bevacizumab is safe and stable when stored at 4 degrees Celsius

Bevacizumab Safe, Stable for Multiple Dosing From Single Vial

0
No evidence of infection, inflammation when bevacizumab is stored at 4° Celsius for a week
Pharmacological thromboprophylaxis does not reduce the risk of venous thromboembolism in patients with cirrhosis

Pharmacological Prophylaxis Doesn’t Cut VTE in Cirrhosis

0
Low rate of VTE in hospitalized patients with cirrhosis; unaffected by pharmacological prophylaxis
The accuracy of blood glucose meters in the low glycemic range is questionable

Blood Glucose Meter Accuracy Unclear at Low Glycemic Range

0
Raises questions regarding safety for measuring blood glucose, and when BGMs are used in trials
The antibiotic dicloxacillin may lessen the effects of vitamin K antagonists

Antibiotic May Reduce Anticoagulant Effect of Warfarin

0
Doctors should closely monitor patients who have to take these drugs together, researcher says
Taking two 12-week courses of alefacept -- a drug already approved to treat psoriasis -- may help people with newly diagnosed type 1 diabetes mellitus preserve pancreatic β-cell function

Psoriasis Med May Help Preserve Pancreas Function in Type 1 DM

0
Used early after diagnosis, medication appears to have long-lasting effects
Testosterone therapy doesn't appear to increase the risk of venous thromboembolism

No Link Found Between Testosterone Therapy and VTE

0
Finding based on data from more than 30,000 American men, 40 and older